A detailed history of Atria Investments LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Atria Investments LLC holds 5,981 shares of MRNA stock, worth $220,399. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,981
Previous 6,433 7.03%
Holding current value
$220,399
Previous $763,000 47.71%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$63.64 - $125.14 $28,765 - $56,563
-452 Reduced 7.03%
5,981 $399,000
Q2 2024

Aug 13, 2024

SELL
$101.21 - $166.61 $358,587 - $590,299
-3,543 Reduced 35.52%
6,433 $763,000
Q1 2024

May 21, 2024

BUY
$85.37 - $115.44 $851,651 - $1.15 Million
9,976 New
9,976 $1.06 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.